戻る Agenda
Hybrid Study Designs: An Innovative Approach to Obtaining Valuable Information by Combining Existing Data with New Data Length
Session Chair(s)
Margaret Richards, PHD, MPH
Open to Work
Pharmacoepidemiology / RWE, United States
Speakers will share innovative approaches to obtaining valuable information by combining existing data with new data.
Learning Objective : Define what constitutes a hybrid study design; Explain why hybrid designs are more cost efficient than traditional study designs; Describe at least one example of a hybrid study design.
Speaker(s)
Leveraging Real-World Data to Plan and Execute Hybrid Studies for Peri- and Postapproval Drug and Device Research
Hady Khoury, MD
Medable, United States
Chief Development Officer
Why Choose a Hybrid Design? Insights from a Study with Duchenne Muscular Dystrophy Patients and Caregivers
William C. Maier, PHD, MPH
Mapi, United Kingdom
Chief Scientific Officer, Head, Patient-Centered Sciences
Feedback from a Hybrid Study in Oncology: Benefits of Combining Prospective Data and Existing Retrospective Data in One Place
Bertrand Le Bourgeois, MSC
Pharmarketing, France
General Manager